Apollomics (APLM) Director Tsai Hsien-Shu Receives Award, Vests RSUs

What Happened

• Director Tsai Hsien-Shu received a grant and had restricted stock units (RSUs) vest. The Form 4 reports a 2,000-share derivative award (grant) on 2026-09-14 (reported at $0.00 as a derivative award) and the vesting/conversion of 500 RSUs on 2026-09-15 (acquired at $0.00). The filing also shows a simultaneous disposition of 500 shares on 2026-09-15 (reported at $0.00). No open-market purchases or cash sales are reported; these are compensation/derivative-related transactions, not typical buy/sell trades.

Key Details

• Transaction dates/prices:
  • 2026-09-14: 2,000-share award (derivative), $0.00 (grant).
  • 2026-09-15: 500 RSUs vested/converted to shares, $0.00 (acquired).
  • 2026-09-15: 500 shares disposed, $0.00 (same day).
• Shares owned after transaction: Not disclosed in this Form 4.
• Notable footnotes:
  • F1: Each RSU equals a contingent right to one Class A ordinary share.
  • F2: The 2,000-share option vests over one year — 50% on Mar 14, 2027 and 50% on Sep 14, 2027, contingent on continued service.
  • F3: The 500-share activity on Sep 15, 2026 represents the scheduled vesting of RSUs previously reported; the simultaneous disposition is shown but the Form 4 does not state the reason.
• Filing timeliness: Form 4 was filed on 2026-09-17 after the Sept 14–15 transactions; this appears to meet the typical two-business-day reporting deadline.

Context

• The 2,000-share item is a derivative award (stock option) with future vesting dates—no immediate market purchase. The 500 RSUs that vested converted to shares; the same-day disposition of 500 shares is often associated with tax withholding or delivery mechanics but the filing does not specify the cause. These types of compensation-based transactions are common for executives and directors and do not necessarily indicate a buy/sell market signal.